• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

资源有限环境下HIV耐药性对一线和二线治疗的影响：由HIV与抗HIV耐药性协作网络组织的研讨会报告

Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.

作者信息

Pillay Deenan, Albert Jan, Bertagnolio Silvia, Boucher Charles, Brun-Vezinet Francoise, Clotet Bonaventura, Giaquinto Carlo, Perno Carlo F

机构信息

Research Department of Infection, University College London, London, UK.

出版信息

Antivir Ther. 2013;18(6):831-6. doi: 10.3851/IMP2650. Epub 2013 Jun 5.

DOI:10.3851/IMP2650
PMID:23740717
Abstract

Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of first-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

摘要

在此，我们总结了2012年10月举行的一次专家研讨会的讨论内容和结论，该研讨会旨在探讨在资源有限的环境中扩大抗逆转录病毒治疗和预防服务规模的背景下，艾滋病毒耐药性所带来的影响。研讨会上审议的主题包括耐药性对一线治疗方案选择和治疗顺序、最佳监测策略以及预防母婴传播的影响。

相似文献

1
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.资源有限环境下HIV耐药性对一线和二线治疗的影响：由HIV与抗HIV耐药性协作网络组织的研讨会报告
Antivir Ther. 2013;18(6):831-6. doi: 10.3851/IMP2650. Epub 2013 Jun 5.
2
Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.预防母婴传播艾滋病毒的抗逆转录病毒疗法：聚焦单剂量奈韦拉平
Clin Drug Investig. 2006;26(11):611-27. doi: 10.2165/00044011-200626110-00001.
3
Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.少数群体中人类免疫缺陷病毒1型耐药性突变与母婴传播的预防：资源有限国家的视角
AIDS Rev. 2014 Oct-Dec;16(4):187-98.
4
Prevention of vertical transmission of HIV-1 in resource-limited settings.在资源有限的环境下预防 HIV-1 的垂直传播。
Expert Rev Anti Infect Ther. 2010 Oct;8(10):1163-75. doi: 10.1586/eri.10.94.
5
Development of antiretroviral resistance in children with HIV in low- and middle-income countries.中低收入国家儿童中 HIV 抗药性的发展。
J Infect Dis. 2013 Jun 15;207 Suppl 2(Suppl 2):S85-92. doi: 10.1093/infdis/jit115.
6
The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.在发展中国家抗逆转录病毒药物推广过程中对艾滋病毒耐药性监测的要求。
Curr Opin Infect Dis. 2006 Dec;19(6):607-14. doi: 10.1097/QCO.0b013e3280109ff1.
7
Antiretroviral (ARV) drug resistance in the developing world.发展中世界的抗逆转录病毒（ARV）药物耐药性。
Evid Rep Technol Assess (Full Rep). 2007 Sep(156):1-74.
8
HIV drug resistance in mothers and infants following use of antiretrovirals to prevent mother-to-child transmission.使用抗逆转录病毒药物预防母婴传播后母婴的艾滋病毒耐药性。
Curr HIV Res. 2013 Mar;11(2):126-36. doi: 10.2174/1570162x11311020005.
9
Monitoring antiretroviral therapy in resource-limited settings: balancing clinical care, technology, and human resources.在资源有限的环境中监测抗逆转录病毒疗法：平衡临床护理、技术和人力资源。
Curr HIV/AIDS Rep. 2010 Aug;7(3):168-74. doi: 10.1007/s11904-010-0046-4.
10
[Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].[优化资源以降低成本，从而在资源有限的环境中确定HIV病毒载量]
Biomedica. 2017 Dec 1;37(4):460-465. doi: 10.7705/biomedica.v37i4.3318.

引用本文的文献

1
Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation.初治和经治 HIV-1 感染者携带 M184V 突变的治疗管理挑战。
Viruses. 2024 Aug 30;16(9):1392. doi: 10.3390/v16091392.
2
Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen.拉米夫定/替诺福韦酯富马酸是一种合适的暴露前预防方案。
Drugs. 2020 Dec;80(18):1881-1888. doi: 10.1007/s40265-020-01419-4.
3
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
在资源有限的环境下，对于正在从一线方案转换至二线方案的大量治疗的患者，进行 HIV-1 耐药性检测至关重要：来自喀麦隆常规临床实践的证据。
BMC Infect Dis. 2019 Mar 12;19(1):246. doi: 10.1186/s12879-019-3871-0.
4
Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection.拉米夫定 25 年：目前和未来用于治疗 HIV-1 感染。
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):125-135. doi: 10.1097/QAI.0000000000001660.
5
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.南非夸祖鲁-纳塔尔省农村地区病毒学失败的儿童中的耐药性。
AIDS Res Ther. 2014 Jan 20;11(1):3. doi: 10.1186/1742-6405-11-3.
6
Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.在非洲的抗逆转录病毒治疗项目中实施 HIV-1 基因型耐药性检测：需求、机遇和挑战。
AIDS Rev. 2013 Oct-Dec;15(4):221-9.